222 related articles for article (PubMed ID: 15310983)
61. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
[TBL] [Abstract][Full Text] [Related]
62. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
63. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
Thompson RH; Cheville JC; Lohse CM; Webster WS; Zincke H; Kwon ED; Frank I; Blute ML; Leibovich BC
Cancer; 2005 Jul; 104(1):53-60. PubMed ID: 15895375
[TBL] [Abstract][Full Text] [Related]
64. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
[TBL] [Abstract][Full Text] [Related]
65. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
[TBL] [Abstract][Full Text] [Related]
66. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
67. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
[TBL] [Abstract][Full Text] [Related]
68. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
[TBL] [Abstract][Full Text] [Related]
69. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma.
Terrone C; Cracco C; Guercio S; Bollito E; Poggio M; Scoffone C; Tarabuzzi R; Porpiglia F; Scarpa RM; Fontana D; Rocca Rossetti S
Eur Urol; 2004 Oct; 46(4):472-6. PubMed ID: 15363563
[TBL] [Abstract][Full Text] [Related]
70. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
71. Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey.
Yurut-Caloglu V; Caloglu M; Kaplan M; Oz-Puyan F; Karagol H; Ibis K; Cosar-Alas R; Kocak Z; Inci O
Eur J Cancer Care (Engl); 2010 Sep; 19(5):656-63. PubMed ID: 19832896
[TBL] [Abstract][Full Text] [Related]
72. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
73. Organ-confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size.
Zubac DP; Bostad L; Kihl B; Eide J; Wentzel-Larsen T; Haukaas SA
APMIS; 2008 Dec; 116(12):1027-33. PubMed ID: 19133004
[TBL] [Abstract][Full Text] [Related]
74. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.
Kroeger N; Rampersaud EN; Patard JJ; Klatte T; Birkhäuser FD; Shariat SF; Lang H; Rioux-Leclerq N; Remzi M; Zomorodian N; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2012 Feb; 187(2):418-23. PubMed ID: 22177164
[TBL] [Abstract][Full Text] [Related]
75. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma.
Sukov WR; Lohse CM; Leibovich BC; Thompson RH; Cheville JC
J Urol; 2012 Jan; 187(1):54-9. PubMed ID: 22088335
[TBL] [Abstract][Full Text] [Related]
76. [Prognostic value of erythrocyte polyamines levels in renal cell carcinoma. Prospective study in 418 cases].
Bigot P; Lughezzani G; Bensalah K; Rioux-Leclercq N; Guillé F; Lobel B; Moulinoux JP; Catros-Quemener V; Cipolla B; Azzouzi AR; Karakiewicz P; Patard JJ
Prog Urol; 2010 Apr; 20(4):272-8. PubMed ID: 20380989
[TBL] [Abstract][Full Text] [Related]
77. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.
Thoroddsen A; Einarsson GV; Hardarson S; Petursdottir V; Magnusson J; Jonsson E; Gudbjartsson T
Scand J Urol Nephrol; 2008; 42(2):121-5. PubMed ID: 18365922
[TBL] [Abstract][Full Text] [Related]
78. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.
Zini L; Destrieux-Garnier L; Leroy X; Villers A; Haulon S; Lemaitre L; Koussa M
J Urol; 2008 Feb; 179(2):450-4; discussion 454. PubMed ID: 18076946
[TBL] [Abstract][Full Text] [Related]
79. Conditional survival predictions after nephrectomy for renal cell carcinoma.
Karakiewicz PI; Suardi N; Capitanio U; Isbarn H; Jeldres C; Perrotte P; Sun M; Ficarra V; Zigeuner R; Tostain J; Mejean A; Cindolo L; Pantuck AJ; Belldegrun AS; Zini L; de la Taille A; Chautard D; Descotes JL; Shariat SF; Valeri A; Mulders PF; Lang H; Lechevallier E; Patard JJ
J Urol; 2009 Dec; 182(6):2607-12. PubMed ID: 19836798
[TBL] [Abstract][Full Text] [Related]
80. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
Karakiewicz PI; Trinh QD; Bhojani N; Bensalah K; Salomon L; de la Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Schips L; Zigeuner R; Mulders PF; Valeri A; Descotes JL; Mejean A; Patard JJ
Eur Urol; 2007 Jun; 51(6):1616-24. PubMed ID: 17207909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
